Clinical trial
Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With…
NCT00152932 · University Health Network, Toronto, Other · Unknown status
Key facts
| NCT number | NCT00152932 |
|---|---|
| Title | Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide |
| Official title | Ocular Blood Flow Measured by HRF and CLBF in Newly Diagnosed and Early Glaucoma Patients Before and After Instillation of Dorzolamide 2% |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Merck Frosst Canada Ltd. Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Glaucoma |
| Intervention type | Device, Drug |
| Interventions | Dorzolamide 2% drops, HRF and CLBF |
| Enrollment | 17 |
| Start date | May 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Sep 9, 2005 |
| Last update posted | Jul 25, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: